Abstract
Genetic testing is an important factor in an array of biomarkers that help patients and clinicians to estimate an individual’s risk for developing Late-Onset Alzheimer’s Disease. This array of tests makes more feasible the possibility of choosing to end one’s life before one becomes demented. These new possibilities raise important ethical issues. Should clinicians, researchers, and regulators seek to erect roadblocks in the path of individuals who seek this information, in a paternalistic attempt to thwart rational suicide? Do volunteers in research have a right to the “return of research results,” to use those results as they see fit? Should we think of suicide in the face of impending dementia as one rational choice to preserve one’s identity before the loss of self that is associated with Alzheimer’s, or should we continue to view suicide as either selfish, or deranged, or both?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.